From Minor Monitoring to Major Insight: Predicting AF Development in the Congenital Heart Disease Population
Journal of Cardiovascular Development and Disease · 24.06.2026 · 13 (7) · 293
DOI: 10.3390/jcdd13070293 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cardiovascular Development and Disease, online erschienen am 24.06.2026. Verfasst von Can Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Erasmus Medical Center, 3015 GD Rotterdam, The Netherlands. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIRCULAR, Dutch Heart Foundation, Dutch Research Council.
Abstract (Originalsprache)
Background
The prognostic value of electrocardiography (ECG)- and continuous rhythm monitoring (CRM)-derived markers for predicting atrial fibrillation (AF) onset and progression remains unclear in patients with congenital heart disease (CHD).
Methods
We retrospectively analyzed 573 CHD patients who underwent 24 h Holter monitoring between 2003 and 2015. Baseline ECG and CRM parameters were assessed. Cox regression identified predictors of new-onset AF and AF progression, and interaction analyses explored effect modification by left atrial (LA) dilatation.
Results
During 13 ± 5 years of follow-up, AF occurred in 107 patients (18.7%), of whom 32 (29.9%) progressed to persistent/permanent AF (PeAF). Patients with AF more frequently had prolonged PR and QTc intervals and higher atrial ectopy (AE) and ventricular ectopy burdens. Independent predictors of new-onset AF were older age, LA dilatation, higher AE burden, atrial tachycardia, and pacemaker implantation. AF progression was independently associated with older age, LA dilatation, higher AE burden, and prolonged PR interval. AE burden showed a stronger association with AF risk in patients without LA dilatation.
Conclusions
In CHD patients, baseline ECG PR-intervals and CRM-derived AE burden independently predict AF onset and/or progression. These noninvasive markers may improve risk stratification and support earlier personalized rhythm management.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Erasmus Medical Center, 3015 GD Rotterdam, The Netherlands.
- Department of Cardiology, Chongqing General Hospital, Chongqing 401147, China.
- Department of Cardiothoracic Surgery, Erasmus Medical Center, 3015 GD Rotterdam, The Netherlands.
- Department of Microelectronics, Signal Processing Systems, Faculty of Electrical Engineering, Mathematics and Computer Sciences, Delft University of Technology, 2628 CD Delft, The Netherlands.
ORCID-Profile: Can Zhang, Lixia Dai, Annemien E van den Bosch, Vehpi Yildirim, Mathijs S van Schie, Natasja M S de Groot
Förderung
- CIRCULAR
- Dutch Heart Foundation
- Dutch Research Council
Zitieren
APA
Zhang, C., Dai, L., van den Bosch, A. E., Yildirim, V., van Schie, M. S., Taverne, Y. J. H. J., & de Groot, N. M. S. (2026). From Minor Monitoring to Major Insight: Predicting AF Development in the Congenital Heart Disease Population. Journal of Cardiovascular Development and Disease, 13(7), 293. https://doi.org/10.3390/jcdd13070293
Vancouver
Zhang C, Dai L, van den Bosch AE, Yildirim V, van Schie MS, Taverne YJHJ, et al. From Minor Monitoring to Major Insight: Predicting AF Development in the Congenital Heart Disease Population. Journal of Cardiovascular Development and Disease. 2026;13(7):293. doi:10.3390/jcdd13070293
BibTeX
@article{Zhang2026,
author = {Zhang, Can and Dai, Lixia and van den Bosch, Annemien E and Yildirim, Vehpi and van Schie, Mathijs S and Taverne, Yannick J H J and de Groot, Natasja M S},
title = {From Minor Monitoring to Major Insight: Predicting AF Development in the Congenital Heart Disease Population},
journal = {Journal of Cardiovascular Development and Disease},
year = {2026},
volume = {13},
number = {7},
pages = {293},
doi = {10.3390/jcdd13070293}
}
EUVIMED